FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jonathan Kaplan

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Geographic Areas

Procedures

CD4 Lymphocyte Count

Concepts & Ideas

Activities & Behaviors

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
John T Brooks; Jonathan E Kaplan; Henry Masur
What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
John T Brooks; Jonathan E Kaplan; King K Holmes; Constance Benson; Alice Pau; Henry Masur
HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines.
Eyasu H Teshale; Debra L Hanson; Mitchell I Wolfe; John T Brooks; Jonathan E Kaplan; Zuleika Bort; Sullivan Patrick
Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jonathan Kaplan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: John T Brooks; Jonathan E Kaplan; Henry Masur
What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
Topics in HIV medicine : a publication of the International AIDS Society, USA 2009;17(3):109-14.
2009: John T Brooks; Jonathan E Kaplan; King K Holmes; Constance Benson; Alice Pau; Henry Masur
HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):609-11.
2007: Eyasu H Teshale; Debra L Hanson; Mitchell I Wolfe; John T Brooks; Jonathan E Kaplan; Zuleika Bort; Sullivan Patrick
Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(6):879-83.
2004: Jonathan E Kaplan
Diagnosis, treatment, and prevention of selected common HIV-related opportunistic infections in the Caribbean region.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2004;12(5):136-41.
2004: Alison Morris; Jens D Lundgren; Henry Masur; Peter D Walzer; Debra L Hanson; Toni Frederick; Laurence Huang; Charles B Beard; Jonathan E Kaplan
Current epidemiology of Pneumocystis pneumonia.
Emerging infectious diseases 2004;10(10):1713-20.
2004: Hillard Weinstock; Irum Zaidi; Walid Heneine; Diane Bennett; J Gerardo Garcia-Lerma; John M Douglas; Marlene LaLota; Gordon M Dickinson; Sandra Schwarcz; Lucia V Torian; Deborah A Wendell; Sindy Paul; Garald A Goza; Juan Ruiz; Brian Boyett; Jonathan E Kaplan
The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.
The Journal of infectious diseases 2004;189(12):2174-80.
2003: Jonathan E Kaplan; Debra L Hanson; David L Cohn; John M Karon; Susan E Buskin; Melanie Thompson; Patricia Fleming; Mark Steven Dworkin
When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(7):951-8.
2003: J Gerardo García-Lerma; Hamish MacInnes; Diane Bennett; Patrick Reid; Soumya Nidtha; Hillard Weinstock; Jonathan E Kaplan; Walid Heneine
A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.
Journal of virology 2003;77(10):5685-93.
2002: Jonathan E Kaplan; Henry Masur; King K Holmes
Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control 2002;51(RR-8):1-52.
2001: Jonathan E Kaplan; Debra L Hanson; Jeffrey L Jones; Mark Steven Dworkin
Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents.
AIDS (London, England) 2001;15(14):1831-6.
2001: Mark Steven Dworkin; J Williamson; Jeffrey L Jones; Jonathan E Kaplan
Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(3):393-8.
2001: Mark Steven Dworkin; John W Ward; Debra L Hanson; Jeffrey L Jones; Jonathan E Kaplan
Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(5):794-800.
2001: Jonathan E Kaplan; Kent A Sepkowitz; Henry Masur; T Sirisanthana; M Russo; L Chapman
Opportunistic infections in persons with HIV or other immunocompromising conditions.
Emerging infectious diseases 2001;7(3 Suppl):541.
2000: Mark Steven Dworkin; Debra L Hanson; Jonathan E Kaplan; Jeffrey L Jones; John W Ward
Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds.
The Journal of infectious diseases 2000;182(2):611-5.
2000: Louisa E Chapman; Timothy A Green; F Ahmed; Bharat Parekh; David Rimland; Jonathan E Kaplan; M A Thompson; Thomas M Folks
Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 x 10(6) cells/l.
AIDS (London, England) 2000;14(9):1135-46.
2000: Jonathan E Kaplan; Henry Masur; King K Holmes; K A Freedberg; David Holtgrave; S C Piscitelli; Russell Van Dyke; Heather Watts
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30 Suppl 1():S15-28.
2000: Jonathan E Kaplan; D Hanson; Mark Steven Dworkin; Toni Frederick; Jeanne Bertolli; Mary Lou Lindegren; Scott Holmberg; Jeffrey L Jones
Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30 Suppl 1():S5-14.
2000: Jonathan E Kaplan; Jeffrey L Jones; C A Dykewicz
Protists as opportunistic pathogens: public health impact in the 1990s and beyond.
The Journal of eukaryotic microbiology 2000;47(1):15-20.
2000: Thomas R Navin; David Rimland; Jeffrey Lennox; John A Jernigan; M Cetron; Allen W Hightower; Jacquelin M Roberts; Jonathan E Kaplan
Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus.
The Journal of infectious diseases 2000;181(1):158-64.
1999: Jonathan E Kaplan; D L Parham; L Soto-Torres; K van Dyck; J A Greaves; K Rauch; B Ellis; H E Amandus
Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States.
Journal of acquired immune deficiency syndromes (1999) 1999;21(3):228-35.
1999: Jeffrey L Jones; Debra L Hanson; Mark Steven Dworkin; D L Alderton; Patricia L Fleming; Jonathan E Kaplan; J Ward
Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries / Centers for Disease Control 1999;48(2):1-22.
1998: Jonathan E Kaplan; Debra L Hanson; Thomas R Navin; Jeffrey L Jones
Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis.
The Journal of infectious diseases 1998;178(4):1126-32.
1998: Jonathan E Kaplan; G Roselle; Kent A Sepkowitz
Opportunistic infections in immunodeficient populations.
Emerging infectious diseases 1998;4(3):421-2.
1998: Jeffrey L Jones; Debra L Hanson; Mark Steven Dworkin; Jonathan E Kaplan; John W Ward
Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996.
The Journal of infectious diseases 1998;178(1):114-20.
1996: Jeffrey L Jones; Debra L Hanson; Susan Y Chu; Carol A Ciesielski; Jonathan E Kaplan; John W Ward; Thomas R Navin
Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. The Adult/Adolescent Spectrum of Disease Group.
AIDS (London, England) 1996;10(12):1393-9.
1996: Ronald C Hershow; Noya Galai; K Fukuda; J Graber; David Vlahov; G Rezza; R S Klein; Don C Des Jarlais; C Vitek; R Khabbaz; Sally Freels; R Zuckerman; Patrizio Pezzotti; Jonathan E Kaplan
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.
The Journal of infectious diseases 1996;174(2):309-17.
1995: Walid Heneine; William Switzer; M Busch; R F Khabbaz; Jonathan E Kaplan
Molecular subtyping of human T-cell lymphotropic virus type 2 by single-strand conformation polymorphism analysis. Retrovirus Epidemiology Donor Study Group.
Journal of clinical microbiology 1995;33(12):3260-3.
1995: T C Woods; J M Graber; Ronald C Hershow; R F Khabbaz; Jonathan E Kaplan; Walid Heneine
Investigation of proviral load in individuals infected with human T-lymphotropic virus type II.
AIDS research and human retroviruses 1995;11(10):1235-9.
1995: F Gracia; L C Castillo; M Larreategui; B Roberts; V Cedeño; Walid Heneine; William A Blattner; Jonathan E Kaplan; Paul H Levine
Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(2):192-7.
1995: Kenneth G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; Jonathan E Kaplan; R Khabbaz; Steven K H Foung
Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.
Blood 1995;86(4):1392-9.
1995: Jonathan E Kaplan; H Masur; King K Holmes; C M Wilfert; R Sperling; S A Baker; C B Trapnell; K A Freedberg; Deborah Cotton; W G Powderly
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21 Suppl 1():S12-31.
1995: Jonathan E Kaplan; H Masur; King K Holmes; Michael M McNeil; Lawrence B Schonberger; Thomas R Navin; Debra L Hanson; P A Gross; Harold W Jaffe
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21 Suppl 1():S1-11.
1995: Jeffrey L Jones; Patricia L Fleming; Carol A Ciesielski; Dale J Hu; Jonathan E Kaplan; John W Ward
Coccidioidomycosis among persons with AIDS in the United States.
The Journal of infectious diseases 1995;171(4):961-6.
1995: C R Vitek; F I Gracia; R Giusti; K Fukuda; D B Green; L C Castillo; B Armien; R F Khabbaz; Paul H Levine; Jonathan E Kaplan
Evidence for sexual and mother-to-child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama.
The Journal of infectious diseases 1995;171(4):1022-6.
1995: Nicholas W Lerche; Walid Heneine; Jonathan E Kaplan; T Spira; J L Yee; R F Khabbaz
An expanded search for human infection with simian type D retrovirus.
AIDS research and human retroviruses 1995;11(4):527-9.
1995: William Switzer; Danuta Pieniazek; P Swanson; H H Samdal; V Soriano; R F Khabbaz; Jonathan E Kaplan; Renu B Lal; Walid Heneine
Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.
Journal of virology 1995;69(2):621-32.
1993: D Pardi; Jonathan E Kaplan; J E Coligan; Thomas M Folks; Renu B Lal
Identification and characterization of an extended Tax protein in human T-cell lymphotropic virus type II subtype b isolates.
Journal of virology 1993;67(12):7663-7.
1993: Walid Heneine; Nicholas W Lerche; T Woods; T Spira; J M Liff; W Eley; J L Yee; Jonathan E Kaplan; R F Khabbaz
The search for human infection with simian type D retroviruses.
Journal of acquired immune deficiency syndromes 1993;6(9):1062-6.
1993: D Pardi; William Switzer; Kenneth G Hadlock; Jonathan E Kaplan; Renu B Lal; Thomas M Folks
Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian.
Journal of virology 1993;67(8):4659-64.
1993: Renu B Lal; C Buckner; R F Khabbaz; Jonathan E Kaplan; G Reyes; Kenneth G Hadlock; J Lipka; Steven K H Foung; L Chan; J E Coligan
Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
Clinical immunology and immunopathology 1993;67(1):40-9.
1993: BD Roberts; Steven K H Foung; J J Lipka; Jonathan E Kaplan; Kenneth G Hadlock; G R Reyes; L Chan; Walid Heneine; R F Khabbaz
Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
Journal of clinical microbiology 1993;31(2):260-4.
1992: Walid Heneine; T Woods; D Green; K Fukuda; R Giusti; L Castillo; B Armien; F Gracia; Jonathan E Kaplan
Detection of HTLV-II in breastmilk of HTLV-II infected mothers.
Lancet 1992;340(8828):1157-8.
1992: Jonathan E Kaplan; Elaine J Abrams; Nathan Shaffer; R O Cannon; A Kaul; K Krasinski; Mahrukh Bamji; T M Hartley; B Roberts; B Kilbourne
Low risk of mother-to-child transmission of human T lymphotropic virus type II in non-breast-fed infants. The NYC Perinatal HIV Transmission Collaborative Study.
The Journal of infectious diseases 1992;166(4):892-5.
1992: Walid Heneine; R F Khabbaz; R B Lal; Jonathan E Kaplan
Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.
Journal of clinical microbiology 1992;30(6):1605-7.
1992: R F Khabbaz; I M Onorato; R O Cannon; T M Hartley; B Roberts; B Hosein; Jonathan E Kaplan
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
The New England journal of medicine 1992;326(6):375-80.
1992: Renu B Lal; Donna L Rudolph; Jonathan E Kaplan; Brian Hjelle; Paul H Levine; J E Coligan; Raphael P Viscidi
Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
Virology 1992;186(1):274-9.
1991: Renu B Lal; Walid Heneine; Donna L Rudolph; W B Present; D Hofhienz; T M Hartley; R F Khabbaz; Jonathan E Kaplan
Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.
Journal of clinical microbiology 1991;29(10):2253-8.
1991: R S Janssen; Jonathan E Kaplan; R F Khabbaz; R Hammond; R Lechtenberg; Michael D Lairmore; M A Chiasson; A Punsalang; B Roberts; R R McKendall
HTLV-I-associated myelopathy/tropical spastic paraparesis in the United States.
Neurology 1991;41(9):1355-7.
1991: T M Hartley; G E Malone; R F Khabbaz; Renu B Lal; Jonathan E Kaplan
Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms.
Journal of clinical microbiology 1991;29(6):1125-7.
1991: Walid Heneine; Jonathan E Kaplan; F Gracia; R Lal; B Roberts; Paul H Levine; William C Reeves
HTLV-II endemicity among Guaymi Indians in Panama.
The New England journal of medicine 1991;324(8):565.
1991: Jonathan E Kaplan; B Litchfield; C Rouault; Michael D Lairmore; Chi-Cheng Luo; L Williams; B J Brew; R W Price; R Janssen; Rand Stoneburner
HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient.
Neurology 1991;41(2 ( Pt 1)):192-7.
1991: Andrew J. Saykin; R S Janssen; G C Sprehn; Jonathan E Kaplan; T J Spira; B O'Connor
Longitudinal evaluation of neuropsychological function in homosexual men with HIV infection: 18-month follow-up.
The Journal of neuropsychiatry and clinical neurosciences 1991;3(3):286-98.
1990: Michael D Lairmore; S Jacobson; F Gracia; B K De; L Castillo; M Larreategui; B D Roberts; Paul H Levine; William A Blattner; Jonathan E Kaplan
Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(22):8840-4.
1990: William C Reeves; J R Cutler; F Gracia; Jonathan E Kaplan; L Castillo; T M Hartley; M M Brenes; M Larreategui; S Loo de Lao; C Archbold
Human T cell lymphotropic virus infection in Guaymi Indians from Panama.
The American journal of tropical medicine and hygiene 1990;43(4):410-8.
1990: R F Khabbaz; J M Douglas; F N Judson; R A Spiegel; Michael St. Louis; William L H Whittington; T M Hartley; Michael D Lairmore; Jonathan E Kaplan
Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA.
The Journal of infectious diseases 1990;162(1):241-4.
1990: T M Hartley; R F Khabbaz; R O Cannon; Jonathan E Kaplan; Michael D Lairmore
Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays.
Journal of clinical microbiology 1990;28(4):646-50.
1990: T J Spira; L H Bozeman; K C Sanderlin; D T Warfield; P M Feorino; Robert C Holman; Jonathan E Kaplan; D B Fishbein; C Lopez
Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection.
The Journal of infectious diseases 1990;161(3):567-70.
1990: R F Khabbaz; T M Hartley; Michael D Lairmore; Jonathan E Kaplan
Epidemiologic assessment of screening tests for antibody to human T lymphotropic virus type I (HTLV-I).
American journal of public health 1990;80(2):190-2.
1990: M Davidson; Jonathan E Kaplan; T M Hartley; Michael D Lairmore; A P Lanier
Prevalence of HTLV-I in Alaska Natives.
The Journal of infectious diseases 1990;161(2):359-60.
1990: Jonathan E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.
Journal of acquired immune deficiency syndromes 1990;3(11):1096-101.
1989: Jonathan E Kaplan; R F Khabbaz
HTLV-I: newest addition to blood donor screening.
American family physician 1989;40(2):189-95.
1989: Jonathan E Kaplan; Y Yamamura; E O Ríos-Olivares; R O Cannon; R F Khabbaz; D J Gubler; E N Kaiselburd; T M Hartley; Michael D Lairmore
Seroprevalence of human T lymphotropic virus type I in Puerto Rico.
The American journal of tropical medicine and hygiene 1989;40(6):659-62.
1989: T J Spira; Jonathan E Kaplan; Robert C Holman; L H Bozeman; J K Nicholson; D B Fishbein
Deterioration in immunologic status of human immunodeficiency virus (HIV)-infected homosexual men with lymphadenopathy: prognostic implications.
Journal of clinical immunology 1989;9(2):132-8.
1988: Jonathan E Kaplan; T J Spira; D B Fishbein; L H Bozeman; P F Pinsky; Lawrence B Schonberger
A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy.
JAMA : the journal of the American Medical Association 1988;260(18):2694-7.
1988: L A Sawyer; J J Murphy; Jonathan E Kaplan; P F Pinsky; D Chacon; S Walmsley; Lawrence B Schonberger; A Phillips; K Forward; C Goldman
25- to 30-nm virus particle associated with a hospital outbreak of acute gastroenteritis with evidence for airborne transmission.
American journal of epidemiology 1988;127(6):1261-71.
1988: G P Holmes; Jonathan E Kaplan; N M Gantz; A L Komaroff; Lawrence B Schonberger; S E Straus; J F Jones; R E Dubois; Charlotte Cunningham-Rundles; Savita Pahwa
Chronic fatigue syndrome: a working case definition.
Annals of internal medicine 1988;108(3):387-9.
1988: R S Janssen; Andrew J. Saykin; Jonathan E Kaplan; T J Spira; P F Pinsky; G C Sprehn; J C Hoffman; W B Mayer; Lawrence B Schonberger
Neurological symptoms and neuropsychological abnormalities in lymphadenopathy syndrome.
Annals of neurology 1988;23 Suppl():S17-8.
1988: R S Janssen; Andrew J. Saykin; Jonathan E Kaplan; T J Spira; P F Pinsky; G C Sprehn; J C Hoffman; W B Mayer; Lawrence B Schonberger
Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome.
Annals of neurology 1988;23(1):49-55.
1987: Jonathan E Kaplan
Guidelines for prevention of herpesvirus Simiae (B-virus) infection in monkey handlers.
Laboratory animal science 1987;37(6):709-12.
1987: T J Spira; Jonathan E Kaplan; P M Feorino; D T Warfield; D B Fishbein; L H Bozeman
Human immunodeficiency virus viremia as a prognostic indicator in homosexual men with lymphadenopathy syndrome.
The New England journal of medicine 1987;317(17):1093-4.
1987: G P Holmes; Jonathan E Kaplan; John A Stewart; B Hunt; P F Pinsky; Lawrence B Schonberger
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?
JAMA : the journal of the American Medical Association 1987;257(17):2297-302.
1987: Jonathan E Kaplan; T J Spira; D B Fishbein; P F Pinsky; Lawrence B Schonberger
Lymphadenopathy syndrome in homosexual men. Evidence for continuing risk of developing the acquired immunodeficiency syndrome.
JAMA : the journal of the American Medical Association 1987;257(3):335-7.
1985: D B Fishbein; Jonathan E Kaplan; T J Spira; B Miller; Lawrence B Schonberger; P F Pinsky; J P Getchell; V S Kalyanaraman; J S Braude
Unexplained lymphadenopathy in homosexual men. A longitudinal study.
JAMA : the journal of the American Medical Association 1985;254(7):930-5.
1985: Jonathan E Kaplan; T J Spira; P M Feorino; D T Warfield; D B Fishbein
HTLV-III viremia in homosexual men with generalized lymphadenopathy.
The New England journal of medicine 1985;312(24):1572-3.